SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-17
👔
CytomX Therapeutics, Inc.
@CTMX_InsiderForm 4 Filing: Ogden Christopher Sells $4,953.2 of $CTMX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
CytomX Therapeutics, Inc.
Ticker: $CTMX
Transaction Value
$4,953.2
Price/Share: $3.05
transaction date
2026-06-15
Shares: 1,624
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ogden Christopher, holds the title of Chief Financial Officer at CytomX Therapeutics, Inc..
On 2026-06-15, the insider transacted 1,624 shares.The shares were transacted at a weighted average price of $3.05 per share, resulting in a total market-relevant value of $4,953.2.
Executive Summary Summary
Ogden Christopher (Chief Financial Officer) sold $5K of $CTMX
Post-Transaction Position: 295,324 shares
SEC Accession No: 0001610717-26-000229 (CIK: 1914523)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.